查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1527307

全球支气管内瓣膜市场规模研究，依产品类型（鸭嘴形、伞形）、最终用户（医院、临床研究中心、门诊手术中心等）及2022-2032年区域预测

Global Endobronchial Valves Market Size Study, by Product Type (Duckbill-Shaped, Umbrella-Shaped), by End User (Hospitals, Clinical Research Center, Ambulatory Surgery Center, Others) and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年，全球支气管内瓣膜市场价值约为1.7115亿美元，预计在2024-2032年预测期内将以超过5.9%的健康成长率成长。支气管内瓣膜是一种主要用于治疗严重肺气肿（慢性阻塞性肺病 (COPD) 的形式）的医疗设备。使用微创支气管镜检查程序将这些小型单向阀植入肺部气道。一旦就位，它们就会允许空气排出肺部过度膨胀的患病部分，但会阻止空气进入这些区域。此过程可减少肺部过度充气，并将气流重新引导至肺部更健康的部位，进而提高呼吸效率。透过缓解压力和减少患病肺段的体积，支气管内瓣膜有助于增强整体肺功能，缓解呼吸短促等症状，并提高患者的生活品质。此手术通常适用于不适合进行肺部减容手术或肺移植等更具侵入性手术介入的患者。与肺部相关的健康问题，特别是慢性阻塞性肺病（COPD）的日益流行，正在推动对支气管内瓣膜等创新医疗设备的需求。根据《美国呼吸与重症医学杂誌》通报，慢性阻塞性肺病是死亡的主要原因，每年夺走约 300 万人的生命。这令人震惊的统计数据强调了对有效治疗方案的需求，包括支气管内瓣膜促进的微创手术，由于减少了创伤，与传统的开放性手术相比，这种手术越来越受到青睐。

根据世界卫生组织国际临床试验註册平台报告，支气管内瓣膜市场也受到大量针对 COPD 的临床试验的支持，其中有 600 多项正在进行的研究。这种活跃的研究格局凸显了人们对发现慢性阻塞性肺病新治疗方法日益增长的兴趣和投资，预计这将推动支气管内瓣膜市场向前发展。例如，2022 年 11 月在 MDPI 上发表的一项研究强调了慢性阻塞性肺病支气管镜治疗的进展，反映了该领域为增强治疗选择所做的持续努力。此外，人们越来越认识到支气管镜肺减容术是治疗肺部相关健康问题的可行方法，这进一步推动了市场的发展。然而，由于市场参与者数量有限，支气管镜瓣膜相关的成本较高，这对更广泛的市场扩张构成了挑战。

全球支气管内瓣膜市场研究考虑的关键区域包括亚太地区、北美、欧洲、拉丁美洲、中东和非洲，由于慢性阻塞性肺病的高盛行率和健全的医疗保健，北美在 2023 年占据最大的市场份额基础设施。该地区对临床试验和创新治疗的关注，以及 FDA 对 Zephyr 和 Spiration 阀门等设备的批准，巩固了其市场主导地位。由于空气污染和职业危害等因素导致人口老化和肺部疾病发病率上升，亚太地区预计将快速成长。

目录

第 1 章：全球支气管内瓣膜市场执行摘要

  • 全球支气管内瓣膜市场规模及预测（2022-2032）
  • 区域概要
  • 分部摘要
    • 依产品类型
    • 按最终用户
  • 主要趋势
  • 经济衰退的影响
  • 分析师推荐与结论

第 2 章：全球支气管内瓣膜市场定义与研究假设

  • 研究目的
  • 市场定义
  • 研究假设
    • 包容与排除
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的角度）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者意识和接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第 3 章：全球支气管内瓣膜市场动态

  • 市场驱动因素
    • 肺部相关问题的盛行率上升
    • 烟草消费量和吸烟率增加
  • 市场挑战
    • 支气管镜瓣膜成本高
  • 市场机会
    • 医疗器材的技术进步
    • 越来越多的慢性阻塞性肺病治疗临床试验

第 4 章：全球支气管内瓣膜市场产业分析

  • 波特的五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争竞争
    • 波特五力模型的未来方法
    • 波特的 5 力影响分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会的
    • 技术性
    • 环境的
    • 合法的
  • 顶级投资机会
  • 最佳制胜策略
  • 颠覆性趋势
  • 产业专家视角
  • 分析师推荐与结论

第 5 章：全球支气管内瓣膜市场规模与预测：依产品类型 - 2022-2032

  • 细分仪表板
  • 全球支气管内瓣膜市场：2022 年及 2032 年产品类型收入趋势分析
    • 鸭嘴形
    • 伞形

第 6 章：全球支气管内瓣膜市场规模和预测：按最终用户分类 - 2022-2032

  • 细分仪表板
  • 全球支气管内瓣膜市场：2022 年和 2032 年最终用户收入趋势分析
    • 医院
    • 临床研究中心
    • 日间手术中心
    • 其他的

第 7 章：全球支气管内瓣膜市场规模及预测：按地区 - 2022-2032

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 荷兰
    • 西班牙
    • 俄罗斯
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 南非
    • 中东和非洲其他地区

第 8 章：竞争情报

  • 重点企业SWOT分析
  • 顶级市场策略
  • 公司简介
    • Pulmonx Corporation
      • 关键讯息
      • 概述
      • 财务（视数据可用性而定）
      • 产品概要
      • 市场策略
    • Olympus Corporation
    • Spiration Inc. (a subsidiary of Olympus)
    • Boston Scientific Corporation
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Broncus Medical Inc.
    • ALung Technologies, Inc.
    • BTG International Ltd. (a subsidiary of Boston Scientific)
    • PneumRx, Inc. (a BTG company)
    • Innovative Airway Solutions
    • IntraPace, Inc.
    • Uptake Medical Corporation
    • Novatech SA
    • TARIS Biomedical LLC

第 9 章：研究过程

  • 研究过程
    • 资料探勘
    • 分析
    • 市场预测
    • 验证
    • 出版
  • 研究属性
简介目录

Global Endobronchial Valves Market is valued approximately at USD 171.15 million in 2023 and is anticipated to grow with a healthy growth rate of more than 5.9% over the forecast period 2024-2032. Endobronchial valves are medical devices used primarily to treat severe emphysema, a form of chronic obstructive pulmonary disease (COPD). These small, one-way valves are implanted in the airways of the lungs using a minimally invasive bronchoscopy procedure. Once in place, they allow air to exit the over-inflated, diseased parts of the lungs but prevent air from entering these areas. This process reduces lung hyperinflation and redirects airflow to healthier parts of the lung, thereby improving breathing efficiency. By relieving pressure and reducing the volume of the diseased lung sections, endobronchial valves help enhance overall lung function, alleviate symptoms like shortness of breath, and improve the patient's quality of life. The procedure is generally considered for patients who are not candidates for more invasive surgical interventions like lung volume reduction surgery or lung transplantation. The increasing prevalence of lung-related health issues, notably chronic obstructive pulmonary disease (COPD), is driving the demand for innovative medical devices like endobronchial valves. COPD is a leading cause of mortality, claiming approximately 3 million lives annually, according to the American Journal of Respiratory and Critical Care Medicine. This alarming statistic underscores the need for effective treatment options, including minimally invasive procedures facilitated by endobronchial valves, which are increasingly preferred over traditional open surgeries due to reduced trauma.

The Endobronchial Valves Market is also bolstered by the significant number of clinical trials focused on COPD, as reported by the WHO International Clinical Trials Registry Platform, with over 600 ongoing studies. This active research landscape highlights the growing interest and investment in discovering new treatment methodologies for COPD, which is expected to propel the endobronchial valves market forward. For instance, a study published in MDPI in November 2022 emphasized the advancements in bronchoscopic management for COPD, reflecting the ongoing efforts to enhance therapeutic options in this field. Moreover, rising awareness about bronchoscopic lung volume reduction as a viable treatment for lung-related health issues is further driving the market. However, the high cost associated with bronchoscopic valves, driven by the limited number of market players, poses a challenge to broader market expansion.

The key regions considered for the Global Endobronchial Valves Market study include Asia Pacific, North America, Europe, Latin America, and the Middle East and Africa, North America held the largest market share in 2023, driven by the high prevalence of COPD and robust healthcare infrastructure. The region's focus on clinical trials and innovative treatments, alongside FDA approvals for devices like Zephyr and Spiration valves, reinforces its market dominance. The Asia Pacific region is expected to grow rapidly due to the aging population and increasing incidence of lung diseases, driven by factors such as air pollution and occupational hazards.

Major market players included in this report are:

  • Pulmonx Corporation
  • Olympus Corporation
  • Spiration Inc. (a subsidiary of Olympus)
  • Boston Scientific Corporation
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Broncus Medical Inc.
  • ALung Technologies, Inc.
  • BTG International Ltd. (a subsidiary of Boston Scientific)
  • PneumRx, Inc. (a BTG company)
  • Innovative Airway Solutions
  • IntraPace, Inc.
  • Uptake Medical Corporation
  • Novatech SA
  • TARIS Biomedical LLC

The detailed segments and sub-segment of the market are explained below:

By Product Type:

  • Duckbill-Shaped
  • Umbrella-Shaped

By End User:

  • Hospitals
  • Clinical Research Center
  • Ambulatory Surgery Center
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Endobronchial Valves Market Executive Summary

  • 1.1. Global Endobronchial Valves Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product Type
    • 1.3.2. By End User
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Endobronchial Valves Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Endobronchial Valves Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Prevalence of Lung-Related Issues
    • 3.1.2. Increasing Tobacco Consumption and smoking rate
  • 3.2. Market Challenges
    • 3.2.1. High Cost of Bronchoscopic Valves
  • 3.3. Market Opportunities
    • 3.3.1. Technological Advancements in Medical Devices
    • 3.3.2. Growing Clinical Trials for COPD Treatments

Chapter 4. Global Endobronchial Valves Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Endobronchial Valves Market Size & Forecasts by Product Type 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Endobronchial Valves Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 5.2.1. Duckbill-Shaped
    • 5.2.2. Umbrella-Shaped

Chapter 6. Global Endobronchial Valves Market Size & Forecasts by End User 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Endobronchial Valves Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million)
    • 6.2.1. Hospitals
    • 6.2.2. Clinical Research Center
    • 6.2.3. Ambulatory Surgery Center
    • 6.2.4. Others

Chapter 7. Global Endobronchial Valves Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Endobronchial Valves Market
    • 7.1.1. U.S. Endobronchial Valves Market
      • 7.1.1.1. Product Type breakdown size & forecasts, 2022-2032
      • 7.1.1.2. End User breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Endobronchial Valves Market
  • 7.2. Europe Endobronchial Valves Market
    • 7.2.1. UK Endobronchial Valves Market
    • 7.2.2. Germany Endobronchial Valves Market
    • 7.2.3. France Endobronchial Valves Market
    • 7.2.4. Italy Endobronchial Valves Market
    • 7.2.5. Netherlands Endobronchial Valves Market
    • 7.2.6. Spain Endobronchial Valves Market
    • 7.2.7. Russia Endobronchial Valves Market
    • 7.2.8. Rest of Europe Endobronchial Valves Market
  • 7.3. Asia-Pacific Endobronchial Valves Market
    • 7.3.1. China Endobronchial Valves Market
    • 7.3.2. India Endobronchial Valves Market
    • 7.3.3. Japan Endobronchial Valves Market
    • 7.3.4. Malaysia Endobronchial Valves Market
    • 7.3.5. Indonesia Endobronchial Valves Market
    • 7.3.6. South Korea Endobronchial Valves Market
    • 7.3.7. Rest of Asia Pacific Endobronchial Valves Market
  • 7.4. Latin America Endobronchial Valves Market
    • 7.4.1. Brazil Endobronchial Valves Market
    • 7.4.2. Mexico Endobronchial Valves Market
    • 7.4.3. Argentina Endobronchial Valves Market
    • 7.4.4. Rest of Latin America Endobronchial Valves Market
  • 7.5. Middle East & Africa Endobronchial Valves Market
    • 7.5.1. Saudi Arabia Endobronchial Valves Market
    • 7.5.2. UAE Endobronchial Valves Market
    • 7.5.3. Israel Endobronchial Valves Market
    • 7.5.4. South Africa Endobronchial Valves Market
    • 7.5.5. Rest of Middle East & Africa Endobronchial Valves Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Pulmonx Corporation
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. Olympus Corporation
    • 8.3.3. Spiration Inc. (a subsidiary of Olympus)
    • 8.3.4. Boston Scientific Corporation
    • 8.3.5. Medtronic plc
    • 8.3.6. Merit Medical Systems, Inc.
    • 8.3.7. Broncus Medical Inc.
    • 8.3.8. ALung Technologies, Inc.
    • 8.3.9. BTG International Ltd. (a subsidiary of Boston Scientific)
    • 8.3.10. PneumRx, Inc. (a BTG company)
    • 8.3.11. Innovative Airway Solutions
    • 8.3.12. IntraPace, Inc.
    • 8.3.13. Uptake Medical Corporation
    • 8.3.14. Novatech SA
    • 8.3.15. TARIS Biomedical LLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes